In an international collaboration, researchers have determined that psychiatric disorders may have important molecular similarities that are not reflected in current diagnostic categories.
Scientists have identified novel genes associated with a specific form of schizophrenia, which could potentially aid diagnosis and development of treatments.
Over a third of adults in the USA may be unknowingly using prescription medications that could increase the risk of depression and suicide.
A novel study reveals that the placenta could play an imperative role in schizophrenia and possibly other neurodevelopmental disorders.
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
Low levels of vasopressin may be linked to low social ability in monkeys and autism in children, indicating that the hormone could be a biomarker for autism.
In this week’s industry news round-up, we’ve chosen the latest updates from a wide range of disorders extending from depression to multiple sclerosis.
A new study has revealed that a nasal spray formulation of ketamine demonstrates promise in the rapid treatment of symptoms of major depression and suicidal thoughts.
In this week’s round-up, we cover the latest industry news from depression and Parkinson’s disease. Find out more about our selection of the highlights this week.
A recent study has reported that long-term consumption of caffeine has negative effects for Alzheimer’s disease, potentially worsening the neuropsychiatric symptoms in those affected by the disorder.